PASG - Passage Bio, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.52 0.01 (0.06%)	---	---	---	---	0.01 (0.06%)	---	---

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -2.96
Diluted EPS:: -2.96
Basic P/E:: -2.8801
Diluted P/E:: -2.8801
RSI(14) 1m:: 26.9
VWAP:: 8.5
RVol:: 0.6602

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	8.77 +0.37 (+4.4%)	Oct 15 11:33
60m	Price decrease 60m	8.33 -0.46 (-5.2%)	Oct 15 11:30
1m	Price decrease 1m	8.5 -0.1 (-1.16%)	Oct 15 11:26
1m	Price increase 1m	8.8 +0.13 (+1.51%)	Oct 15 10:57
1m	Price increase 1m	8.8 +0.13 (+1.51%)	Oct 15 10:57